Explore more publications!

US Manufacturing Reporter Press Releases

Labels On
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
Info
 United States Generative AI cybersecurity market is expected to reach USD 35 billion by 2031 | DataM Intelligence 2025
Intwo Expands Cybersecurity & Azure Cloud Services to Strengthen Digital Transformation for U.S. Enterprises
PureCycle, Churchill Container Win U.S. Plastics Pact Sustainable Packaging Innovation Award for PCR Content
Wrap and K-Form Strengthen Made in America Supply Chain for Wrap’s Non-Lethal Response and CUAS Manufacturing
Victoria’s Secret & Co. Invites You to Listen to the Third Quarter 2025 Earnings Call Webcast
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
China’s #1 AI Coffee Robot Hits 98% Consistency – Anno Robot Leads 2025 Vending Surge
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
Amneal Receives U.S. FDA Approval for Iohexol Injection
Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants
High-end Italian Interior Designer Febal Casa opening new U.S. store in Las Vegas
Private Biotech Summit Strengthens Korea–U.S. Pathways in Trials and AI Platforms
U.S. Officially Ends Penny Era After Over Two Centuries

U.S. Officially Ends Penny Era After Over Two Centuries

SemiCab Launches New AI Logistics SaaS Platform to Transform the $450 Billion U.S. Full-Truckload Market
Mobilicom Provides Third Quarter 2025 Update and Financial Highlights: Substantial Increase in Sales to U.S. Market
Viasat Successfully Tests HaloNet Launch Telemetry Solution for NASA Onboard Blue Origin’s New Glenn
Doseology Completes Extensive North American Diligence, Securing Strategic Manufacturing Agreement via U.S. Subsidiary Doseology USA Inc.
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom
Why North American Brands Are Replacing Traditional Print with Video Brochures in 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions